000			02150 a2200625 4500
005			20250517165155.0
264		0	_c20180622
008			201806s 0 0 eng d
022			_a1440-1746
024	7		_a10.1111/jgh.13912 _2doi
040			_aNLM _beng _cNLM
100	1		_aLiu, Chen-Hua
245	0	0	_aReal-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan. _h[electronic resource]
260			_bJournal of gastroenterology and hepatology _cMar 2018
300			_a710-717 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_a2-Naphthylamine
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnilides _xadministration & dosage
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aCarbamates _xadministration & dosage
650	0	4	_aCyclopropanes
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aLactams, Macrocyclic
650	0	4	_aMacrocyclic Compounds _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProline _xanalogs & derivatives
650	0	4	_aRetrospective Studies
650	0	4	_aRibavirin _xadministration & dosage
650	0	4	_aRitonavir _xadministration & dosage
650	0	4	_aSafety
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aTaiwan
650	0	4	_aTreatment Outcome
650	0	4	_aUracil _xadministration & dosage
650	0	4	_aValine
650	0	4	_aViral Load
700	1		_aLiu, Chun-Jen
700	1		_aSu, Tung-Hung
700	1		_aYang, Hung-Chih
700	1		_aHong, Chun-Ming
700	1		_aTseng, Tai-Chung
700	1		_aChen, Pei-Jer
700	1		_aChen, Ding-Shinn
700	1		_aKao, Jia-Horng
773	0		_tJournal of gastroenterology and hepatology _gvol. 33 _gno. 3 _gp. 710-717
856	4	0	_uhttps://doi.org/10.1111/jgh.13912 _zAvailable from publisher's website
999			_c27420967 _d27420967